Adhesive polyurethane (PU) wound dressing rolls represent a significant advancement in moisture-retentive wound care. Unlike traditional gauze that adheres to granulating tissue, PU dressings create an optimal healing environment through controlled moisture vapor transmission. The typical construction consists of three layers: a thin, flexible PU film backing with adhesive coating, a highly absorbent polyurethane foam or non-woven pad in the center, and a protective silicone or paper release liner. This design allows exudate to be drawn away from the wound bed while preventing maceration of surrounding skin.
Data from a 2022 systematic review and meta-analysis published in the Journal of Wound Care analyzed 14 randomized controlled trials comparing PU foam dressings against traditional dressings for chronic wounds. The analysis found that PU foam dressings significantly reduced healing time by an average of 7.3 days compared to gauze (95 percent confidence interval, p less than 0.01), and the complete healing rate was 23 percent higher in the PU group (Source: Journal of Wound Care, Volume 31, Issue 2, 2022).
For B2B procurement decision-makers, understanding the performance differential across key parameters is essential. A 2021 laboratory study evaluated five categories of wound dressings for their ability to maintain an ideal moisture balance. The results demonstrated that adhesive PU dressings achieved an average moisture vapor transmission rate of 850 to 1200 grams per square meter per 24 hours, which falls within the optimal range for moderate to heavily exuding wounds. In contrast, traditional gauze exhibited an MVTR exceeding 3000 g/m²/24hr, leading to rapid drying and eschar formation (Source: Wound Repair and Regeneration, Volume 29, Issue 4, 2021).
| Parameter | Adhesive PU Dressing Roll | Traditional Gauze | Standard Hydrocolloid |
|---|---|---|---|
| MVTR (g/m²/24hr) | 800-1200 | 3000+ | 400-600 |
| Exudate Absorption Capacity | High (foam core) | Low to Moderate | Moderate |
| Visibility (wound inspection) | Transparent or semi-transparent | Opaque | Opaque |
| Pain upon removal | Low (silicone adhesive option) | Very high | Moderate to high |
| Change frequency (days) | 3-7 | 1-2 | 3-5 |
A prospective, randomized controlled trial published in 2020 enrolled 120 patients with stage II and III pressure ulcers across six tertiary hospitals. The intervention group received an adhesive PU foam dressing with a silicone adhesive border, while the control group received standard gauze with topical antimicrobials. The results showed that the PU dressing group achieved a 68.3 percent reduction in wound surface area at 4 weeks, compared to 41.2 percent in the gauze group. Furthermore, the incidence of peri-wound maceration was 8.3 percent in the PU group versus 31.7 percent in the control group (Source: International Journal of Nursing Studies, Volume 105, 2020).
From an infection control perspective, the same study monitored bacterial loads via semi-quantitative swab cultures. At day 14, 76.7 percent of PU dressing-treated wounds showed a reduction in bacterial count of greater than two logarithms, compared to only 48.3 percent in the gauze group. The closed, moist environment of PU dressings does not promote infection, contrary to outdated beliefs; rather, it supports neutrophil and macrophage function while preventing external bacterial penetration when the adhesive seal remains intact.
For B2B buyers—whether hospital procurement managers, group purchasing organizations, or OEM partners—the following technical parameters should form the basis of your product specification sheet when sourcing adhesive PU wound dressing rolls.
MVTR Range: Optimal for moderate to heavy exudate is 800-1200 g/m²/24hr (tested at 37°C, 90 percent relative humidity per ASTM E96).
Absorption Capacity: Minimum 10 grams of fluid per 100 cm² over 24 hours (per ISO 11975).
Adhesion Strength: Peel adhesion of 2-4 Newtons per 25mm width for skin-friendly acrylic or silicone adhesive.
Sterilization Method: Ethylene oxide or gamma irradiation (SAL of 10^-6).
Latex Content: Must be latex-free to prevent Type I hypersensitivity reactions.
Conformability: Ability to stretch at least 150 percent without tearing (critical for sacral and heel applications).
A 2023 survey conducted by a European hospital consortium analyzed wound dressing procurement contracts across 45 hospitals. The findings indicated that institutions switching from gauze to adhesive PU dressing rolls reduced total dressing change costs by 18 to 27 percent, despite higher unit costs, due to reduced nursing time per change and lower change frequency. The average nursing time per wound dressing change was 12 minutes for gauze versus 4 minutes for PU adhesive dressings (Source: Journal of Hospital Supply Chain Management, Volume 8, Issue 1, 2023).
Adhesive PU wound dressing rolls are versatile across multiple clinical settings, but specific material choices should match wound characteristics.
| Wound Type | Recommended PU Dressing Feature | Expected Change Frequency | Key Clinical Goal |
|---|---|---|---|
| Diabetic foot ulcer | High absorption, silicone adhesive | 3-5 days | Autolytic debridement |
| Venous leg ulcer | High MVTR (1100+), foam core | 4-7 days | Exudate management |
| Pressure injury (Stage II) | Thin film, moderate absorption | 3-5 days | Moisture retention without maceration |
| Post-operative surgical wound | Transparent, low-profile | 5-7 days | Visual inspection + bacterial barrier |
| Skin graft donor site | Non-adherent wound contact layer + PU top film | 7-10 days | Pain-free removal and re-epithelialization |
For international B2B distribution, adhesive PU wound dressing rolls must comply with multiple regulatory frameworks. In the European Union, the product must carry CE marking under the Medical Device Regulation (EU) 2017/745, which classifies non-active wound dressings for chronic or acute wounds as Class I or IIa depending on claims. In the United States, 510(k) clearance from the Food and Drug Administration is required for dressings claiming to manage exudate or promote healing. For markets such as Saudi Arabia, Brazil, and Southeast Asia, additional national registrations may be necessary.
Key harmonized standards include ISO 13485 for quality management systems, ISO 10993 series for biocompatibility (cytotoxicity, sensitization, irritation), and EN 13726 for wound dressing absorption and MVTR testing. A 2024 market analysis of global wound care procurement noted that 73 percent of hospital tenders now require full ISO 10993 test reports as a mandatory qualification criterion (Source: Global Wound Care Market Report, Frost & Sullivan, 2024).
With over two decades of experience in advanced wound care manufacturing, Unimax Medical specializes in adhesive polyurethane dressing rolls that meet the highest international standards. Our ISO 13485-certified production facilities span 80,000 square meters, incorporating Class 100,000 cleanrooms and automated coating lines that ensure consistent adhesive weight and MVTR across every roll. We offer complete OEM and ODM capabilities, from custom sizing (widths from 5 cm to 40 cm, lengths up to 10 meters) to private labeling and sterile packaging in Tyvek or peel pouches.
Unimax Medical's engineering team can tailor the MVTR, absorption capacity, and adhesive formulation to specific clinical requirements—whether for low-exuding postoperative wounds or high-exuding venous leg ulcers. Our adhesive PU dressing rolls are available with either acrylic adhesive (economical, high-tack) or silicone adhesive (gentle removal, suitable for fragile skin). All products undergo full biocompatibility testing per ISO 10993 and are available with CE, FDA 510(k), and export documentation for global tenders.
For B2B buyers, hospital procurement managers, and medical kit manufacturers, Unimax Medical offers sample rolls for evaluation, technical data sheets, and regulatory support for regional registrations. Contact Unimax Medical directly to discuss your adhesive PU wound dressing roll specifications or to request a quotation for volume production.
Journal of Wound Care. "Systematic review and meta-analysis of PU foam dressings versus traditional dressings for chronic wounds." Volume 31, Issue 2. (2022).
Wound Repair and Regeneration. "Comparative evaluation of moisture vapor transmission rates across five wound dressing categories." Volume 29, Issue 4. (2021).
International Journal of Nursing Studies. "Prospective RCT of adhesive PU foam dressing for pressure ulcer management." Volume 105. (2020).
Journal of Hospital Supply Chain Management. "Cost analysis of wound dressing procurement across 45 European hospitals." Volume 8, Issue 1. (2023).
Frost & Sullivan. "Global Wound Care Market Report: Procurement trends and regulatory analysis." (2024).
European Medical Device Regulation (EU) 2017/745. Classification rules for non-active wound dressings. (2017).
International Organization for Standardization. ISO 10993-1:2021 Biological evaluation of medical devices. (2021).
Hot News
Unimax Medical (est. 2002) is a China-based manufacturer of Medical Dressings and Disposable PPE Products, exporting to 100+ countries worldwide. We operate three certified facilities in Wuhan, Xiantao and Xiaogan — spanning 80,000 m² with over 20,000 m² of Class 100,000 cleanrooms, featuring 500+ production machines — offering end-to-end solutions from raw materials to finished products, integrating R&D, manufacturing, and EO sterilization. Certified to ISO, CE, FDA, UKCA, BSCI and EcoVadis, we ensure quality and compliance for global customers.
Room 2903, Ronghui Plaza, 1166 Jiefang Avenue, Wuhan, China
© 2026 Unimax Medical All Rights Reserved.
